To describe the characteristics and obesity management approaches of older adults enrolled in nationally representative Medicare Advantage (MA) health plans.

A ≥40% relative decline in estimated glomerular filtration rate (eGFR) has been supported for use as a surrogate endpoint for clinical outcomes. However, the associations between this change and resulting days that a patient spends out of their primary ambulatory residence (e.g., during inpatient admissions and nursing facility stays) and cost outcomes are limited. The purpose of this analysis was to evaluate the associations of relative changes in eGFR with days out of the home and with cost outcomes in patients with type 2 diabetes mellitus (T2DM).

Research supporting the validity of changes in estimated glomerular filtration rate (eGFR) as a surrogate endpoint for end-stage kidney disease (ESKD) or other clinical outcomes in patients with type 2 diabetes mellitus (T2DM) is limited. The primary purpose of this study was to evaluate the association between relative changes in eGFR and clinical outcomes in patients with T2DM.